BRIDGET Trial: Strategies in Maintenance Therapy for HER2+ Breast Cancer with Brain Metastases

Panelists discuss the progress of the BRIDGET trial and its potential impact on HER2-positive breast cancer patients, focusing on the anticipated data and its implications for treatment strategies in this population.

EP: 1.Overview of HER2 Breast Cancer

EP: 2.HER2+ Breast Cancer Diagnosis: Insights From Patients and Clinicians

EP: 3.Coordinating Care for HER+ Breast Cancer Patients: A Multidisciplinary Approach

EP: 4.Multidisciplinary Care of HER2+ Breast Cancer: A Patient Perspective

EP: 5.Tailoring Patient Education and Resources in HER2+ Breast Cancer

EP: 6.Navigating HER2+ Breast Cancer Treatment: A Patient's Journey

EP: 7.Navigating Systemic Therapy Options in HER2+ Breast Cancer

EP: 8.Key Insights from the HER2CLIMB Trial

EP: 9.Key Insights From the DEBBRAH and HER2CLIMB-02 Studies

Now Viewing

EP: 10.BRIDGET Trial: Strategies in Maintenance Therapy for HER2+ Breast Cancer with Brain Metastases

EP: 11.Preparing Patients for Treatment: Education, Administration and Adverse Effect Management in HER2+ Breast Cancer

EP: 12.Patient Perspectives on Managing Adverse Effects from Capecitabine, Trastuzumab, and Tucatinib

Dr Iyengar: Briefly discuss the BRIDGET trial's progress and the potential impact of its anticipated data on HER2-positive breast cancer patients?

Recent Videos